SCHEMBL23917423

SCHEMBL23917423

Oc1cc(N2CCCc3ccccc32)cc(N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
ROCK1 Q13464 1/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
AKT1 P31749 1/20 0.37
PIK3CA P42336 1/20 0.37
NUDT1 P36639 1/20 0.37
NOTUM Q6P988 1/20 0.37
HTT P42858 2/20 0.36
MGLL Q99685 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
OPRM1 P35372 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917695 0.88 ROCK1 (0.40) SIGMAR1SMN1; SMN2MAPTMAPK1ROCK1
SCHEMBL23917712 0.87 ROCK1 (0.39) SIGMAR1SMN1; SMN2MAPTMAPK1ROCK1
SCHEMBL23917696 0.85 ALDH1A1 (0.41) SMN1; SMN2MAPTMAPK1ROCK1MEN1
SCHEMBL23917574 0.81 ROCK1 (0.38) SIGMAR1SMN1; SMN2MAPTMAPK1ROCK1
SCHEMBL23908721 0.81 EED (0.38) SIGMAR1SMN1; SMN2MAPTMAPK1ROCK1
SCHEMBL23917429 0.80 TSHR (0.38) SMN1; SMN2MAPTMAPK1ROCK1MEN1
SCHEMBL24043567 0.80 ROCK1 (0.37) SIGMAR1SMN1; SMN2MAPTMAPK1ROCK1
SCHEMBL22989296 0.79 AKT1 (0.36) SMN1; SMN2MAPTMAPK1ROCK1MEN1
SCHEMBL23908720 0.79 MEN1 (0.44) SIGMAR1SMN1; SMN2MAPTROCK1MEN1
SCHEMBL31410786 0.79 MEN1 (0.44) SIGMAR1SMN1; SMN2MAPTROCK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME ORAI2, SLC39A11, SLC39A7 SIGMAR1 4503/4885SMN1; SMN2 4340/4885MAPT 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.